A Systematic Review of Literature to Evaluate the Burden of Physical and Psychological Symptoms and Palliative Care in Patients Diagnosed with Idiopathic Pulmonary Fibrosis

Overview

Journal Afr J Thorac Crit Care Med

Date 2021 Jul 21

PMID 34286243

Citations 2

Authors

M F van Jaarsveld

L Gwyther

Affiliations

Soon will be listed here.

Abstract

Background: Palliative care improves quality of life in patients with life-threatening illnesses, such as idiopathic pulmonary fibrosis (IPF), in a holistic manner and should be integrated early into the management of these patients.

Objective: To evaluate the degree of physical and psychological symptoms in patients with IPF and the extent to which palliative care is used in patient management.

Methods: Several databases were searched for studies reporting on symptom burden, quality of life or palliative interventions in patients with IPF.

Results: A total of 46 articles were included in this review. Studies showed that many patients experienced dyspnoea, which improved with pulmonary rehabilitation in some cases. Fatigue and poor quality of sleep had a notable negative impact on daily life activities. Instruments evaluating anxiety and depression showed that many patients with IPF experienced mild to moderate depression and anxiety. Quality of life was shown to be negatively affected across all domains. Two studies indicated poor referral to palliative care units and one study reported positively on the use of morphine for managing breathlessness in advanced IPF.

Conclusion: Patients with IPF generally experience poor quality of life. Patients are seldom referred to palliative care, even in developed countries. No data were available on the use of palliative care in developing countries. Furthermore, research on the burden of symptoms and management of these symptoms appears to be limited. Increased awareness of and research on the palliative care needs of patients with IPF are recommended, particularly in resource-limited settings such as South Africa.

Citing Articles

The Burden of Disability in Africa and Cameroon: A Call for Optimizing the Education in Physical and Rehabilitation Medicine.

Cannata G, Douryang M, Ljoka C, Giordani L, Monticone M, Foti C Front Rehabil Sci. 2022; 3:873362.

PMID: 36188952 PMC: 9397855. DOI: 10.3389/fresc.2022.873362.

Effect of home-based pulmonary rehabilitation on functional capacity in people with idiopathic pulmonary fibrosis-a systematic review protocol.

Amin R, Vaishali K, Maiya G, Mohapatra A, Yadav U, Parsekar S Syst Rev. 2021; 10(1):297.

PMID: 34782011 PMC: 8591795. DOI: 10.1186/s13643-021-01853-9.

References

Jenkinson C, Coulter A, Wright L . Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ. 1993; 306(6890):1437-40. PMC: 1677870. DOI: 10.1136/bmj.306.6890.1437. View

Rajala K, Lehto J, Saarinen M, Sutinen E, Saarto T, Myllarniemi M . End-of-life care of patients with idiopathic pulmonary fibrosis. BMC Palliat Care. 2016; 15(1):85. PMC: 5059981. DOI: 10.1186/s12904-016-0158-8. View

Pihtili A, Bingol Z, Kiyan E, Cuhadaroglu C, Issever H, Gulbaran Z . Obstructive sleep apnea is common in patients with interstitial lung disease. Sleep Breath. 2013; 17(4):1281-8. DOI: 10.1007/s11325-013-0834-3. View

Holland A, Fiore Jr J, Bell E, Goh N, Westall G, Symons K . Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease. Respirology. 2014; 19(8):1215-21. DOI: 10.1111/resp.12360. View

Swigris J, Streiner D, Brown K, Belkin A, Green K, Wamboldt F . Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis. Respir Med. 2014; 108(1):181-8. PMC: 3951298. DOI: 10.1016/j.rmed.2013.12.009. View

Jastrzebski D, Gumola A, Gawlik R, Kozielski J . Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation. J Physiol Pharmacol. 2006; 57 Suppl 4:139-48. View

Lechtzin N, Hilliard M, Horton M . Validation of the Cough Quality-of-Life Questionnaire in patients with idiopathic pulmonary fibrosis. Chest. 2013; 143(6):1745-1749. PMC: 4694113. DOI: 10.1378/chest.12-2870. View

Spencer S, Calverley P, Burge P, Jones P . Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001; 163(1):122-8. DOI: 10.1164/ajrccm.163.1.2005009. View

Atkins C, Gilbert D, Brockwell C, Robinson S, Wilson A . Fatigue in sarcoidosis and idiopathic pulmonary fibrosis: differences in character and severity between diseases. Sarcoidosis Vasc Diffuse Lung Dis. 2016; 33(2):130-8. View

10.

Yusen R, Shearon T, Qian Y, Kotloff R, Barr M, Sweet S . Lung transplantation in the United States, 1999-2008. Am J Transplant. 2010; 10(4 Pt 2):1047-68. DOI: 10.1111/j.1600-6143.2010.03055.x. View

11.

Tzanakis N, Samiou M, Lambiri I, Antoniou K, Siafakas N, Bouros D . Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests. Eur J Intern Med. 2005; 16(2):105-112. DOI: 10.1016/j.ejim.2004.09.013. View

12.

Kolilekas L, Manali E, Vlami K, Lyberopoulos P, Triantafillidou C, Kagouridis K . Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis. J Clin Sleep Med. 2013; 9(6):593-601. PMC: 3659380. DOI: 10.5664/jcsm.2758. View

13.

Lindell K, Kavalieratos D, Gibson K, Tycon L, Rosenzweig M . The palliative care needs of patients with idiopathic pulmonary fibrosis: A qualitative study of patients and family caregivers. Heart Lung. 2016; 46(1):24-29. PMC: 5485906. DOI: 10.1016/j.hrtlng.2016.10.002. View

14.

Mermigkis C, Bouloukaki I, Antoniou K, Papadogiannis G, Giannarakis I, Varouchakis G . Obstructive sleep apnea should be treated in patients with idiopathic pulmonary fibrosis. Sleep Breath. 2014; 19(1):385-91. DOI: 10.1007/s11325-014-1033-6. View

15.

Bajwah S, Higginson I, Ross J, Wells A, Birring S, Riley J . The palliative care needs for fibrotic interstitial lung disease: a qualitative study of patients, informal caregivers and health professionals. Palliat Med. 2013; 27(9):869-76. DOI: 10.1177/0269216313497226. View

16.

Liberati A, Altman D, Tetzlaff J, Mulrow C, Gotzsche P, Ioannidis J . The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med. 2009; 6(7):e1000100. PMC: 2707010. DOI: 10.1371/journal.pmed.1000100. View

17.

Lou P, Zhu Y, Chen P, Zhang P, Yu J, Zhang N . Prevalence and correlations with depression, anxiety, and other features in outpatients with chronic obstructive pulmonary disease in China: a cross-sectional case control study. BMC Pulm Med. 2012; 12:53. PMC: 3503755. DOI: 10.1186/1471-2466-12-53. View

18.

Zimmermann C, Carvalho C, Silveira K, Yamaguti W, Moderno E, Salge J . Comparison of two questionnaires which measure the health-related quality of life of idiopathic pulmonary fibrosis patients. Braz J Med Biol Res. 2007; 40(2):179-87. DOI: 10.1590/s0100-879x2007000200004. View

19.

Allen S, Raut S, Woollard J, Vassallo M . Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis. Palliat Med. 2005; 19(2):128-30. DOI: 10.1191/0269216305pm998oa. View

20.

Mermigkis C, Bouloukaki I, Antoniou K, Mermigkis D, Psathakis K, Giannarakis I . CPAP therapy in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea: does it offer a better quality of life and sleep?. Sleep Breath. 2013; 17(4):1137-43. DOI: 10.1007/s11325-013-0813-8. View